Significance of Serum Ribavirin Concentration in Combination Therapy of Interferon and Ribavirin for Chronic Hepatitis C-Reference-Cited by-同舟云学术

Significance of Serum Ribavirin Concentration in Combination Therapy of Interferon and Ribavirin for Chronic Hepatitis C

Published:2005 Issue:2-3 Volume:48 Page:138-144
ISSN:0300-5526
Container-title:Intervirology
language:en
Short-container-title:Intervirology

Author:

Arase Yasuji,Ikeda Kenji,Tsubota Akihito,Suzuki Fumitaka,Suzuki Yoshiyuki,Saitoh Satoshi,Kobayashi Masahiro,Akuta Norio,Someya Takashi,Hosaka Tetsuya,Sezaki Hitomi,Kobayashi Mariko,Kumada Hiromitsu

Publisher

S. Karger AG

Subject

Infectious Diseases,Virology

Reference24 articles.

1. Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C

2. Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus

3. Randomised, double-blind, placebo-controlled trial of interferon α-2b with and without ribavirin for chronic hepatitis C

4. Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C

5. The impact of interferon plus ribavirin on response to therapy in black patients with chronic hepatitis C

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#;Intensive Care Medicine;2020-05-07

2. Repurposed Oral Ribavirin for Respiratory Virus Infections Requires Pharmacokinetic-pharmacodynamic Dose Optimization;Clinical Infectious Diseases;2019-07-04

3. Population pharmacokinetics of ribavirin in lung transplant recipients and examination of current and alternative dosing regimens;Journal of Antimicrobial Chemotherapy;2018-11-16

4. Dosing ribavirin in hepatitis E-infected solid organ transplant recipients;Pharmacological Research;2018-04

5. Peg-interferon and ribavirin treatment in HIV/HCV co-infected patients in Thailand: efficacy, safety and pharmacokinetics;Tropical Medicine & International Health;2018-01-10